Chemistry & Biochemistry’s Dr. Xiaohua Peng was featured in In Focus discussing her new start-up SynXT Therapeutics. SynXT Therapeutics (founded by Dr. Peng and former UWM graduate student Dr. Taufeeque Ali) are developing a new type of cancer therapy. This …
As we approach the final weeks of the second academic year in the new Chemistry Building, we want to share with you a little behind the scenes perspective on the building planning process with Cannon Design. Cannon Design was awarded …
We congratulate UWM Investigator: Assistant Professor Elizabeth Liedhegner, School of Biomedical Sciences & Health Care Administration and UWM Co-Investigator: Professor Nicholas Silvaggi, Department of Chemistry & Biochemistry as the recipients of a Discovery and Innovation Grant (DIG) for their research …
Promotions Dr. Xiaohua Peng, who joined UWM in 2009, was recently promoted to full professor. Her research explores innovative ways to design tumor-targeted cancer therapies and bioorthogonal theranostic systems, with support from the National Institutes of Health. Her team recently …
For the first time, a compound developed at the Milwaukee Institute for Drug Discovery (MIDD) will enter clinical trials at the U.S. Food and Drug Administration. The drug was developed in part by distinguished professor emeritus Jim Cook of the Chemistry …